Religare's research report on Dabur India Dabur’s posted Q4FY16 consol. sales/EBITDA/adj. PAT growth of 10.9%/20.2%/16.6% YoY with domestic volume growth of 7% YoY aided by improved performance of the foods business. Saving in input cost & lower ad spend drove EBITDA margins to 19.2% (RCMLe 18.6%). Though Dabur’s sequential volume growth has normalized, we believe it’s near term performance could be marred by weak macros and stiff competition from Patanjali. Valuations at 30x FY18E EPS seems rich, maintain SELL.While Dabur’s QoQ volume growth has normalised, we believe near-term growth could to be marred by weak consumer spends and high competitive intensity. Valuations at 34x FY17E and 30x FY18E EPS do not fully discount the medium-term earnings risks in our view. Maintain SELL with a Mar’17 TP of Rs 270.
For all recommendations, click here Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.